Comparing the results to aggressive lymphomas, the authors observed MYC- and NFKB1-mediated dysregulation of miRNA expression in the samples with aggressive lymphomas; they concluded the existence of fundamental differences in miRNA expression between OAMZLs and diffuse large B-cell lymphomas, mainly due to differences in the MYC and NF-κB regulatory pathways [123]. The gene discussed is MYC; the disease is lymphoma.